Partial seizures
Not recruitingStudy on the Effects of Azetukalner in Reducing Focal-Onset Seizures for Patients with Epilepsy
- Disease:Partial seizures
- Substances:–
Spain- Participants:18–64 years · 65+ years
- Sponsor:Xenon Pharmaceuticals Inc.
Rare diseases
Investigational molecules
Locations
Back to Spain191 clinical trials in Valladolid, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on acute ischemic stroke treatment and new therapies for multiple sclerosis. Studies are evaluating novel compounds to improve functional outcomes and testing advanced treatments for episodic migraine in young patients.
Critical research examining combined vaccination approaches for SARS-CoV-2 and Influenza, along with studies on Respiratory Syncytial Virus vaccines in older adults. Innovative treatments for various fungal infections are also being investigated.
Comprehensive studies on multiple myeloma treatments and innovative approaches for bladder cancer. Research includes evaluation of novel drug combinations and personalized treatment strategies for various cancer types.
Advanced research in Type 2 Diabetes management, focusing on personalized genetic-based treatments and innovative insulin therapies. Studies aim to optimize treatment outcomes through tailored approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.